Underweight MDLZ: Staged trim to 50–70% weight with hard stop at $58.56; reject GIS rotation in favor of Treasuries
Underweight with price target $58 reflects the 200 SMA structural floor. The bear case has earned directional conviction on rigorous analysis of margin deterioration (Q1→Q2 160bps gross margin contraction, Q2 operating income -15% sequentially), negative dividend coverage math ($2.25B trailing FCF vs ~$2.5B annual payouts), and unjustified 22.87x PE premium versus peers (Hershey 21x, General Mills 15x, Kraft Heinz 13x). Staged 1–2 week execution avoids being liquidity provider given hawkish Fed backdrop driving income-manager rotation out of defensive equity. A miss on two of four Q3 catalysts likely sends stock to $58–60; a clean beat with raised guidance reopens bull case.
| Position | Action |
|---|---|
| Current levels ($62.40–$62.80) | Trim one-third of position |
| Retest of $63.50–$64.70 resistance zone (Bollinger midline / 50 SMA / failed-breakout high confluence) | Trim remaining two-thirds reserved capacity |
| Confirmed close below $58.56 (200 SMA) on volume ≥8M | Full exit of residual position |
MDLZ is a defensive compounder with accelerating revenue growth (+8.2% YoY Q2), expanding margins (+170bps gross margin expansion), and a coiled-spring technical setup offering a favorable risk-reward at PEG 0.92 with 23% earnings growth potential and multiple innovation catalysts that have already resolved the cocoa-cost bear thesis.
| Indicator | Value | Signal |
|---|---|---|
| close_200_sma | 58.56 | bullish |
| close_50_sma | 61.68 | bullish |
| close_10_ema | 62.21 | neutral |
| rsi | 51.25 | neutral |
| macd | -0.03 | neutral |
| macd_signal | 0.12 | neutral |
| macd_histogram | -0.15 | bearish |
| bollinger_middle | 62.78 | neutral |
| bollinger_upper | 64.82 | neutral |
| bollinger_lower | 60.74 | neutral |
| atr | 1.31 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Confirmed close below $58.56 on volume ≥8M (secular trend rollover)
Then: Downgrade to Sell, opens path to $52–55
↩ rebuts: “Bear thesis that cocoa costs will crush margins — Q2 print proved otherwise”
EV: Target $66.65 (52-week high) on first leg; $70+ on second leg as cocoa normalization flows through margins · concedes: Roughly 75% of revenue is non-U.S. — FX headwind from strong USD on international earnings is real exposure; MDLZ's Net Debt/EBITDA of 3.2x is higher than S&P 500 average of ~1.5x
MDLZ is a yield trap masquerading as a defensive compounder—the dividend is uncovered by free cash flow, margins are deteriorating sequentially (not expanding), the balance sheet carries $43.76B of goodwill at risk of impairment in a hawkish rate environment, and the technical setup shows six weeks of institutional distribution rather than accumulation.
EV: +2.8% (probability-weighted return) · concedes: Consensus does show +23% earnings growth forecast; PEG of 0.92 appears attractively valued on surface; Dividend yield of 3.33% provides current income; Political probability of zero Fed cuts in 2026 (Polymarket 93%) could be wrong, which would help the defensive bid thesis; S&P +12.1% in 6 months proves money is rotating into risk assets, which could reverse if recession odds rise; Base rate of consolidations at highs breaking down vs. up is roughly 50/50, not definitively bearish
→ vs conservative: The conservative view conflates defensive characteristics with asymmetric upside — MDLZ is expensive BECAUSE of its defensive premium, and that multiple only holds if growth and margin trajectory remain intact, which the data shows is breaking
→ vs conservative: Dividend coverage math is brutal: 2.25B in trailing FCF against 2.5B in annual payouts is a structural deficit funded by debt issuance, not well-covered income — you're earning 3.33% with negative real coverage while Treasuries pay 4.5%+
→ vs neutral: The neutral view of waiting for technical confirmation is textbook paralysis — coils release in either direction, and waiting for breakdown below 58.56 means already giving back another six percent chasing the move
→ vs neutral: Six weeks of distribution off the July 29 peak is institutional rotation out, not a bull flag — the technical compression sits at the worst intersection of premium valuation and deteriorating momentum
| neutral |
| close | 62.47 | neutral |
Support: 60.74 · 61.68 · 58.56 | Resistance: 62.21 · 64.82 · 66.65
MDLZ is in a constructive long-term uptrend with price well above rising 50 SMA ($61.68) and 200 SMA ($58.56), but is currently in a short-term consolidation/pause phase. The MACD histogram just turned negative (-0.15) and RSI is neutral at 51.25, with price compressed tightly between the 10 EMA ($62.21) and Bollinger middle band ($62.78). ATR has compressed ~27% from July levels to $1.31, creating a coiled-spring setup. Resistance sits at the upper Bollinger band ($64.82) and July high ($66.65), while support is at the 50 SMA ($61.68) and lower Bollinger band ($60.74). The HOLD rating reflects an absence of fresh bullish triggers; new entries should await either a breakout above $64.82 with positive MACD histogram confirmation, or a successful bounce from the $60.74-$61.68 support zone with bullish RSI divergence.
Market Cap
$79.69 Billion
PE (TTM)
22.87
Forward PE
18.57
PEG Ratio
0.92
Price to Book
3.00
EPS (TTM)
$2.73
Forward EPS
$3.36
Dividend Yield
3.33%
Beta
0.40
52-Week High
$66.65
52-Week Low
$51.20
50-Day Average
$61.68
200-Day Average
$59.20
Revenue (TTM)
$39.67 Billion
Gross Profit (TTM)
$12.36 Billion
EBITDA (TTM)
$6.08 Billion
Net Income (TTM)
$3.52 Billion
Operating Margin (TTM)
21.98%
Net Profit Margin (TTM)
8.86%
Return on Equity (ROE)
13.34%
Return on Assets (ROA)
4.12%
Total Assets
$71.12 Billion
Total Liabilities
$45.32 Billion
Stockholders' Equity
$25.75 Billion
Total Debt
$21.62 Billion
Cash & Equivalents
$1.52 Billion
Net Debt
$19.50 Billion
Goodwill & Intangibles
$43.76 Billion
Net PPE
$11.29 Billion
Current Ratio
0.60
Working Capital
-$10.76 Billion
Debt/Equity
~84%
Net Debt/EBITDA
~3.2x
Operating Cash Flow (TTM)
~$5.0 Billion
Free Cash Flow (TTM)
$2.25 Billion
Annual Dividends Paid
~$2.5 Billion
Annual CapEx
~$1.2-1.5 Billion
Q2 2026 Revenue
$10.08 Billion
Q2 2026 Gross Profit
$2.80 Billion
Q2 2026 Gross Margin
27.8%
Q2 2026 Operating Income
$808 Million
Q2 2026 Net Income
$560 Million
Q2 2026 Diluted EPS
$1.20
Q1 2026 Revenue
$10.50 Billion
Q4 2025 Revenue
$9.74 Billion
Q3 2025 Revenue
$8.98 Billion
Share Count
1.284 Billion
Strengths
Concerns
MDLZ is a global snacking and confectionery giant with iconic brands (Oreo, Cadbury, Toblerone, Milka) generating $39.67B in annual revenue. The stock exhibits defensive characteristics (beta 0.40, 3.33% dividend yield) while delivering accelerating top-line growth (+8.2% YoY in Q2 2026) and 170 bps gross margin expansion. The valuation appears attractive with a PEG ratio of 0.92, though elevated leverage (3.2x Net Debt/EBITDA) and tight dividend coverage by FCF warrant caution. HOLD rating reflects a quality defensive profile with reasonable valuation but limited near-term catalysts and tight dividend coverage by FCF.
Macro: Hawkish-defensive macro backdrop with 93% probability of zero Fed rate cuts in 2026 per Polymarket ($8.27M volume), implying a rate hike is the base case per IBD. August CPI data raised interest-rate expectations, with gold at ~$4,350 rebounding on sticky inflation. Recession odds remain low at 7% US, 6% UK, 6% Japan — soft landing consensus intact. Higher-for-longer rates create mild multiple compression on staples cohort while supporting pricing power in an inflationary regime.